The Washington Supreme Court has dealt a setback to physicians by finding unconstitutional a tort reform measure aimed at curbing meritless medical liability lawsuits.
The Washington Supreme Court has dealt a setback to physicians by finding unconstitutional a tort reform measure aimed at curbing meritless medical liability lawsuits.
State law required patients to submit a statement from a medical expert certifying the existence of a reasonable basis for allegations when the lawsuit was initially filed.
According to American Medical News (10/12/09), the court unanimously ruled that the statute encroached on the court's ability to set its own procedural rules, violating the separation of powers between the legislature and the judiciary. Justices argued that the measure conflicted with an existing rule barring additional verification of a case.
In a more favorable ruling for physicians, on September 24, 2009, the court also determined that Consumer Protection Act claims could not be included automatically in medical liability cases.
This case arose after a physician prescribed surgery that the patient alleged was unnecessary and from which she developed complications. The patient claimed that the doctor's improper recommendations and the costs of the alleged unnecessary surgery constituted unfair business practices under the state's consumer protection act, entitling her to damages beyond any compensation awarded from her medical liability suit for negligence.
The court ruled that the surgical expenses could not be separated from the medical liability claim and that the state's consumer protection statutes weren't designed to address healthcare decisions and to allow patients to recover damages denied in personal liability actions.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More